Company
Applied BioCode (TWSE:6598)
Innovating multiplex diagnostics for affordable, high-throughput infectious disease detection
Also known as Applied BioCode, Applied BioCode, Inc.
- Status
- IPOas of 2026-09-18
- Business model
- B2B
- Headquarters
- Santa Fe Springs, California, United States
- Customers
- research and clinical laboratories
- Legal name
- Applied BioCode, Inc.
- apbiocode.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Applied BioCode is an in vitro diagnostics (IVD) manufacturer that designs, develops, and commercializes cutting-edge infectious disease multiplex panel tests.
Funding snapshot
- Total raised
- $17.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $9.3M2014-07-15
Funding rounds
- Round, 2014
- $9.3M2014-07-15, SEC form D sold, 13 investors
- Round, 2012
- $7M2012-11-26, SEC form D sold, 12 investors
- Round, 2011
- $1.2M2011-09-30, SEC form D sold, 14 investors
About the company
- Status notes
- TWSE:6598
Products
- Other
- BioCode Gastrointestinal Pathogen Panel
- Hardware
- BioCode MDx-3000 Instrument
- Other
- BioCode Respiratory Pathogen Panel
- Other
- BioCode STI + Resistance Panel
Loading relationship preview